Journal details
EXPERT OPINION ON THERAPEUTIC TARGETS
TAYLOR & FRANCIS LTD · ISSN 1472-8222 · eISSN 1744-7631
SCIEScopusMEDLINEPubMedPMC
Overview
EXPERT OPINION ON THERAPEUTIC TARGETS. ISSN 1472-8222 · eISSN 1744-7631. published by TAYLOR & FRANCIS LTD. England. Pharmacology & Pharmacy. impact factor 5.1 (2025). JCR Q1. CAS Zone 2. indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 46 articles · 2025: 74 articles · 2024: 86 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of EXPERT OPINION ON THERAPEUTIC TARGETS?
The impact factor recorded for EXPERT OPINION ON THERAPEUTIC TARGETS is 5.1 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of EXPERT OPINION ON THERAPEUTIC TARGETS?
EXPERT OPINION ON THERAPEUTIC TARGETS is listed in CAS Zone 2.
Which databases index EXPERT OPINION ON THERAPEUTIC TARGETS?
EXPERT OPINION ON THERAPEUTIC TARGETS is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.